Developer docs
API playgroundTry for free, no card

Search company profiles

Agilex Biolabs

Full company profile

uuid0008qxb

Namestring
Agilex Biolabs
Legal namestring
Agilex Biolabs
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Agilex Biolabs is an Australian contract research organization (CRO) that provides regulated bioanalytical laboratory services to global biotechnology and pharmaceutical companies conducting preclinical and clinical drug development. The company supports pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, biomarker, and GLP toxicology studies for small molecules, biologics, vaccines, cell and gene therapies, and controlled substances including cannabinoids and psychedelics. Founded in 1996 and operating from Thebarton (Adelaide), Brisbane, and Sydney, the company is part of the Healius healthcare network and serves sponsors across the US, Europe, China, and South Korea.

Agilex's technical platform combines 17 LC-MS/MS instruments with MesoScale Discovery and Gyrolab immunoassay systems, BD FACSymphony (20-color) and Cytek Aurora (40-color spectral) flow cytometers, MSD multiplex cytokine panels, ELISpot, and a national PBMC processing network operating under a single standardized SOP. The platform is differentiated by published novel methodologies (notably a CD45 magnetic-isolation-with-serum-co-incubation protocol in Immunohorizons), proprietary PBMC viability stability data underpinning the 24-hour processing window, and the only FDA-inspected bioanalytical lab of its type in the Asia-Pacific region, with three FDA inspections and OECD GLP / ISO 17025 / ISO 27001 accreditation.

Revenue is generated through professional-services contracts on a per-study or multi-year basis, with project fees, per-sample analysis fees, and ongoing retainers. The company reports supporting 80+ clinical trials and 130+ projects annually, analyzing 60,000+ samples per year, with an 85% repeat client rate. Go-to-market is enterprise field sales executed by business development managers in Australia, the US, China, and South Korea, supplemented by active participation at conferences (BIO Korea, BIO Asia Taiwan, Bio-Europe Spring, OCT West Coast, J.P. Morgan Healthcare Conference), educational webinars (including partnerships with Endpoints News), and a scientific content blog. Pricing is quote-based and project-specific, with clients also leveraging Australia's 43.5% R&D tax cash rebate to lower effective study cost.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersThebarton, Australia
HQ citystring
Thebarton
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioanalytical laboratory services, pharmacokinetics bioanalysis, pharmacodynamics testing, clinical trial bioanalysis, immunogenicity testing
Industry4 codes
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code3 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Testing Laboratories and Services54138
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Bioanalytical Laboratory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services (CRO)
TypeProfessional Services
Description

Agilex Biolabs operates as a contract research organization providing bioanalytical laboratory services to biotech and pharma companies conducting preclinical and clinical trials. Services are contracted on a per-study or project basis, typically covering pharmacokinetics, pharmacodynamics, immunogenicity, biomarker analysis, and toxicology. Revenue is generated through project fees, per-sample analysis fees, and service retainers for ongoing client engagements. The company supports over 80 clinical trials annually and analyzes more than 60,000 samples per year.

agilexbiolabs.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details1 tier
1Enterprise contract research services for biotech and pharma companies
ModelOtherBilling cadenceMulti-year contract
Notes

Services are contracted on a per-study basis with quotes provided based on project scope, number of samples, assay types, and regulatory requirements. No standard price list is publicly available.

agilexbiolabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Agilex Biolabs is a contract research organization (CRO) providing regulated bioanalytical laboratory services for preclinical and clinical drug development. Its core offerings include Pharmacokinetics (PK) bioanalysis via LC-MS/MS and immunoassays, Pharmacodynamics (PD) testing including immunogenicity and flow cytometry, biomarker analysis, central lab services, GLP toxicology, PBMC processing, ELISpot, and immunogenicity testing — primarily serving biotech and pharma companies conducting clinical trials in Australia and globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Phase 1 clinical trial initiation in 6-8 weeks in Australia with robust nonclinical program
+4 more records
Product overview1 text field

Agilex Biolabs is Australia's leading bioanalytical Contract Research Organization (CRO) offering a comprehensive suite of laboratory services for preclinical and clinical trials. The company provides an integrated portfolio of services centered around Pharmacokinetics (PK), Pharmacodynamics (PD), Biomarkers, Central Lab Services, Toxicology, and Off the Shelf Assays. Their core offerings include LC-MS/MS bioanalysis, immunoassays, flow cytometry, PBMC processing, and ELISpot analysis, all supported by GLP-compliant toxicology services. The company operates almost 30 years of experience with facilities in Adelaide (headquarters), Brisbane, and Sydney, Australia, serving global biotechnology and pharmaceutical companies conducting clinical research.

Product and service11 records
1Pharmacokinetics (PK) Services
CategoryBioanalytical Services
Description

Study of what the body does to a drug during a clinical study, covering absorption, bioavailability, distribution, metabolism, and excretion. Includes LC-MS/MS bioanalysis, immunoassays (ligand binding assays), and cellular and molecular analysis (Flow/PCR) for biotech and pharma sponsors.

2Pharmacodynamics (PD) Services
CategoryBioanalytical Services
Description

Study of the biochemical, physiological and molecular effects of a therapeutic on the body. Includes immunogenicity ADA/Neutralising Ab assays, vaccine support, cell-based immunology assays, and flow cytometry for nonclinical and clinical programs.

3Biomarkers
CategoryBioanalytical Services
Description

Biomarker analysis services providing essential efficacy, safety, and pathology data around drugs and indications being investigated in preclinical and clinical studies.

4Central Lab Services
CategoryCentral Laboratory Services
Description

Sample lifecycle management from end to end, including kit production for multi-site programs, sample logistics, and distribution to sites of choice for clinical trial sponsors.

5Off the Shelf Assays
CategoryBioanalytical Services
Description

Pre-designed and pre-validated assays, often available in kit form, ready for use without extensive development or optimization, providing time and cost savings for bioanalytical packages.

6Toxicology Services
CategoryToxicology / Preclinical Services
Description

GLP-compliant toxicology services including exploratory toxicology, pharmacokinetic studies, and GLP toxicology studies to support entry to first-in-human clinical trials. Includes rodent studies (Australia) and non-rodent studies via Attentive Sciences collaboration (US), all under a single Agilex contract.

7PBMC Processing Services
CategoryImmunology / Sample Processing
Description

Isolation and cryopreservation of peripheral blood mononuclear cells (PBMCs) using density gradient centrifugation. Delivered via a network of laboratories across Australia operating under a single standardized operating procedure for multicenter clinical trials.

8Flow Cytometry Services
CategoryImmunology / Flow Cytometry
Description

Multiparameter flow cytometry analysis using BD FACSymphony (20 colour, 22 parameters) and three Cytek Aurora spectral flow cytometers (up to 40 colours) for detailed cell phenotyping and immune cell subset assessment in clinical trials.

9ELISpot Analysis
CategoryImmunology / Functional Assays
Description

Enzyme-Linked ImmunoSpot (ELISpot) assay for detecting cytokine-secreting cells at single-cell level, used for antigen-specific T-cell or B-cell responses in vaccine development, immuno-oncology, and autoimmune disease research.

10Immunogenicity Testing
CategoryImmunogenicity / Bioanalytical Services
Description

Assessment of anti-drug antibodies (ADA) and immunogenicity for biotherapeutics, including assay development, validation, and screening to ensure safety and efficacy compliance for clinical trial sponsors.

11In-House PK Data Analysis Service
CategoryData Analysis / PK Modeling
Description

In-house pharmacokinetic data analysis service integrating bioanalysis and PK modeling to reduce turnaround times in single-ascending-dose (SAD) and multiple-ascending-dose (MAD) clinical studies.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Immunovirology Research Network (IVRN) / Australian Centre for HIV and Hepatitis Virology (ACH4)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-22
Description

Agilex Biolabs participated in the Quality Assurance Program (QAP) coordinated by the Immunovirology Research Network (IVRN) of the Australian Centre for HIV and Hepatitis Virology (ACH4) and attained certification for the isolation and cryopreservation of PBMCs. This certification validates Agilex's PBMC processing quality and consistency for clinical trial immunology studies.

agilexbiolabs.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-04
Description

Agilex Biolabs expanded its flow cytometry capabilities by establishing a new Flow Cytometry Laboratory at the QIMR Berghofer Medical Research Institute Campus in Brisbane. This partnership enables Agilex to provide rapid real-time flow cytometry services and PBMC processing in Queensland, supporting immunology bioanalysis for multicenter clinical trials.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2021-08-31
Description

Agilex partnered with Endpoints News to co-host a webinar on 'Non-clinical and clinical pathways for rapid vaccine development in Australia', hosted by Endpoints News Editor Arsalan Arif. The partnership leverages Endpoints News' media reach to promote Agilex's capabilities and the Australian clinical trial advantage to a global biotech/pharma audience.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Agilex established its first satellite processing unit on the fifth floor of the CMAX Clinical Research facility in Adelaide, SA. This enables rapid PBMC processing from Phase 1 clinical trial participants with specialized technicians stationed on-site, supporting time-critical sample processing for psychedelic compounds and other sensitive therapeutics under Agilex's Schedule 9 drug license.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Agilex collaborates with Attentive Sciences in the US for non-rodent toxicology studies (dogs, safety pharmacology) and specialized animal models (mice, rats, guinea pigs, ferrets, hamsters, mini pigs, canines) that are not available in Australia. Under this collaboration, clients can run rodent studies in Australia and non-rodent studies in the US under a single contract through Agilex, with a single point of contact for program management. Offshore study expenses may be eligible for the Australian R&D cash rebate.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Celerion is a clinical pharmacology and bioanalytical services CRO specializing in early-phase clinical research and bioanalysis (PK/PD/immunogenicity), directly comparable to Agilex's core offering for small and large molecules.

TypeDirect peer
Description

Eurofins Bioanalytical Services provides regulated LC-MS/MS and ligand-binding bioanalysis for preclinical and clinical studies, overlapping directly with Agilex's PK, biomarker, and immunogenicity service lines.

TypeDirect peer
Description

Pharmaron offers integrated drug discovery, development, and bioanalytical services including LC-MS/MS bioanalysis, in vivo PK, and immunology assays, serving as a direct competitor in bioanalytical CRO with both Western and APAC presence.

TypeBroad incumbent
Description

Charles River is a global preclinical and bioanalytical CRO providing safety assessment, bioanalysis, and research models. Its discovery/safety division overlaps with Agilex's GLP toxicology and bioanalytical services, though it operates at much greater scale.

TypeBroad incumbent
Description

WuXi AppTec is a leading APAC-headquartered CRO/CDMO with bioanalytical, toxicology, and clinical research services, competing head-to-head with Agilex for global biotech clients seeking APAC bioanalytical capacity.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with end-to-end clinical, bioanalytical, and real-world evidence services. While not specialized like Agilex, it competes for full-service sponsor programs that include bioanalytical work.

TypeBroad incumbent
Description

ICON is a top-tier global CRO providing clinical development and bioanalytical services across all phases, comparable as a broad incumbent that bundles bioanalysis into integrated trial offerings.

TypeBroad incumbent
Description

Fortrea is a global clinical CRO spun out of LabCorp with bioanalytical and central lab capabilities, directly overlapping with Agilex's clinical bioanalysis and central lab services for biotech and pharma sponsors.

TypeBroad incumbent
Description

Intertek provides pharmaceutical and bioanalytical testing services including LC-MS/MS and ligand-binding assays for regulated studies, comparable to Agilex's quality-control bioanalytical workflows.

TypeBroad incumbent
Description

SGS Health Sciences provides clinical research, bioanalytical, and central laboratory services to pharma and biotech, overlapping with Agilex's bioanalytical and central lab offerings from a global, multi-geography footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agilex Biolabs

Bioanalytical Laboratory Servicesagilexbiolabs.com

What Agilex Biolabs does

Agilex Biolabs is an Australian contract research organization (CRO) that provides regulated bioanalytical laboratory services to global biotechnology and pharmaceutical companies conducting preclinical and clinical drug development. The company supports pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, biomarker, and GLP toxicology studies for small molecules, biologics, vaccines, cell and gene therapies, and controlled substances including cannabinoids and psychedelics. Founded in 1996 and operating from Thebarton (Adelaide), Brisbane, and Sydney, the company is part of the Healius healthcare network and serves sponsors across the US, Europe, China, and South Korea.

Agilex's technical platform combines 17 LC-MS/MS instruments with MesoScale Discovery and Gyrolab immunoassay systems, BD FACSymphony (20-color) and Cytek Aurora (40-color spectral) flow cytometers, MSD multiplex cytokine panels, ELISpot, and a national PBMC processing network operating under a single standardized SOP. The platform is differentiated by published novel methodologies (notably a CD45 magnetic-isolation-with-serum-co-incubation protocol in Immunohorizons), proprietary PBMC viability stability data underpinning the 24-hour processing window, and the only FDA-inspected bioanalytical lab of its type in the Asia-Pacific region, with three FDA inspections and OECD GLP / ISO 17025 / ISO 27001 accreditation.

Revenue is generated through professional-services contracts on a per-study or multi-year basis, with project fees, per-sample analysis fees, and ongoing retainers. The company reports supporting 80+ clinical trials and 130+ projects annually, analyzing 60,000+ samples per year, with an 85% repeat client rate. Go-to-market is enterprise field sales executed by business development managers in Australia, the US, China, and South Korea, supplemented by active participation at conferences (BIO Korea, BIO Asia Taiwan, Bio-Europe Spring, OCT West Coast, J.P. Morgan Healthcare Conference), educational webinars (including partnerships with Endpoints News), and a scientific content blog. Pricing is quote-based and project-specific, with clients also leveraging Australia's 43.5% R&D tax cash rebate to lower effective study cost.

Agilex Biolabs firmographics

Firmographics
Name
Agilex Biolabs
Legal name
Agilex Biolabs
Website
https://agilexbiolabs.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Agilex Biolabs industry classification

Industry
Product category
Bioanalytical Laboratory Services
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (54138)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Bioanalytical laboratory services
  • Pharmacokinetics bioanalysis
  • Pharmacodynamics testing
  • Clinical trial bioanalysis
  • Immunogenicity testing

Where Agilex Biolabs is headquartered

Location

Headquarters

HQ city
Thebarton
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

Agilex Biolabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Contract Research Services (CRO): Agilex Biolabs operates as a contract research organization providing bioanalytical laboratory services to biotech and pharma companies conducting preclinical and clinical trials. Services are contracted on a per-study or project basis, typically covering pharmacokinetics, pharmacodynamics, immunogenicity, biomarker analysis, and toxicology. Revenue is generated through project fees, per-sample analysis fees, and service retainers for ongoing client engagements. The company supports over 80 clinical trials annually and analyzes more than 60,000 samples per year.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise contract research services for biotech and pharma companies

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Agilex Biolabs product offering

Product offering

Core offering

Agilex Biolabs is a contract research organization (CRO) providing regulated bioanalytical laboratory services for preclinical and clinical drug development. Its core offerings include Pharmacokinetics (PK) bioanalysis via LC-MS/MS and immunoassays, Pharmacodynamics (PD) testing including immunogenicity and flow cytometry, biomarker analysis, central lab services, GLP toxicology, PBMC processing, ELISpot, and immunogenicity testing — primarily serving biotech and pharma companies conducting clinical trials in Australia and globally.

Product overview

Agilex Biolabs is Australia's leading bioanalytical Contract Research Organization (CRO) offering a comprehensive suite of laboratory services for preclinical and clinical trials. The company provides an integrated portfolio of services centered around Pharmacokinetics (PK), Pharmacodynamics (PD), Biomarkers, Central Lab Services, Toxicology, and Off the Shelf Assays. Their core offerings include LC-MS/MS bioanalysis, immunoassays, flow cytometry, PBMC processing, and ELISpot analysis, all supported by GLP-compliant toxicology services. The company operates almost 30 years of experience with facilities in Adelaide (headquarters), Brisbane, and Sydney, Australia, serving global biotechnology and pharmaceutical companies conducting clinical research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmacokinetics (PK) Services Study of what the body does to a drug during a clinical study, covering absorption, bioavailability, distribution, metabolism, and excretion. Includes LC-MS/MS bioanalysis, immunoassays (ligand binding assays), and cellular and molecular analysis (Flow/PCR) for biotech and pharma sponsors.
  • Pharmacodynamics (PD) Services Study of the biochemical, physiological and molecular effects of a therapeutic on the body. Includes immunogenicity ADA/Neutralising Ab assays, vaccine support, cell-based immunology assays, and flow cytometry for nonclinical and clinical programs.
  • Biomarkers Biomarker analysis services providing essential efficacy, safety, and pathology data around drugs and indications being investigated in preclinical and clinical studies.
  • Central Lab Services Sample lifecycle management from end to end, including kit production for multi-site programs, sample logistics, and distribution to sites of choice for clinical trial sponsors.
  • Off the Shelf Assays Pre-designed and pre-validated assays, often available in kit form, ready for use without extensive development or optimization, providing time and cost savings for bioanalytical packages.
  • Toxicology Services GLP-compliant toxicology services including exploratory toxicology, pharmacokinetic studies, and GLP toxicology studies to support entry to first-in-human clinical trials. Includes rodent studies (Australia) and non-rodent studies via Attentive Sciences collaboration (US), all under a single Agilex contract.
  • PBMC Processing Services Isolation and cryopreservation of peripheral blood mononuclear cells (PBMCs) using density gradient centrifugation. Delivered via a network of laboratories across Australia operating under a single standardized operating procedure for multicenter clinical trials.
  • Flow Cytometry Services Multiparameter flow cytometry analysis using BD FACSymphony (20 colour, 22 parameters) and three Cytek Aurora spectral flow cytometers (up to 40 colours) for detailed cell phenotyping and immune cell subset assessment in clinical trials.
  • ELISpot Analysis Enzyme-Linked ImmunoSpot (ELISpot) assay for detecting cytokine-secreting cells at single-cell level, used for antigen-specific T-cell or B-cell responses in vaccine development, immuno-oncology, and autoimmune disease research.
  • Immunogenicity Testing Assessment of anti-drug antibodies (ADA) and immunogenicity for biotherapeutics, including assay development, validation, and screening to ensure safety and efficacy compliance for clinical trial sponsors.
  • In-House PK Data Analysis Service In-house pharmacokinetic data analysis service integrating bioanalysis and PK modeling to reduce turnaround times in single-ascending-dose (SAD) and multiple-ascending-dose (MAD) clinical studies.

Quantifiable outcome

  • Phase 1 clinical trial initiation in 6-8 weeks in Australia with robust nonclinical program
  • +4 more outcomes

Companies that use Agilex Biolabs

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Agilex Biolabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Agilex Biolabs partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Immunovirology Research Network (IVRN) / Australian Centre for HIV and Hepatitis Virology (ACH4)coreStrategic or Co-development Partner · 22 January 2025Agilex Biolabs participated in the Quality Assurance Program (QAP) coordinated by the Immunovirology Research Network (IVRN) of the Australian Centre for HIV and Hepatitis Virology (ACH4) and attained certification for the isolation and cryopreservation of PBMCs. This certification validates Agilex's PBMC processing quality and consistency for clinical trial immunology studies.
  • QIMR Berghofer Medical Research InstitutecoreStrategic or Co-development Partner · 4 November 2024Agilex Biolabs expanded its flow cytometry capabilities by establishing a new Flow Cytometry Laboratory at the QIMR Berghofer Medical Research Institute Campus in Brisbane. This partnership enables Agilex to provide rapid real-time flow cytometry services and PBMC processing in Queensland, supporting immunology bioanalysis for multicenter clinical trials.
  • Endpoints NewsminorGTM or Marketing Partner · 31 August 2021Agilex partnered with Endpoints News to co-host a webinar on 'Non-clinical and clinical pathways for rapid vaccine development in Australia', hosted by Endpoints News Editor Arsalan Arif. The partnership leverages Endpoints News' media reach to promote Agilex's capabilities and the Australian clinical trial advantage to a global biotech/pharma audience.
  • CMAX Clinical ResearchcoreStrategic or Co-development Partner · 1 January 2020Agilex established its first satellite processing unit on the fifth floor of the CMAX Clinical Research facility in Adelaide, SA. This enables rapid PBMC processing from Phase 1 clinical trial participants with specialized technicians stationed on-site, supporting time-critical sample processing for psychedelic compounds and other sensitive therapeutics under Agilex's Schedule 9 drug license.
  • Attentive SciencescoreStrategic or Co-development Partner · 1 January 2019Agilex collaborates with Attentive Sciences in the US for non-rodent toxicology studies (dogs, safety pharmacology) and specialized animal models (mice, rats, guinea pigs, ferrets, hamsters, mini pigs, canines) that are not available in Australia. Under this collaboration, clients can run rodent studies in Australia and non-rodent studies in the US under a single contract through Agilex, with a single point of contact for program management. Offshore study expenses may be eligible for the Australian R&D cash rebate.

Scale indicators12 records

Recent moves3 records

Expansion highlights6 records

Agilex Biolabs competitors and assessment

Company assessment

Direct peers

  • Celerion: Celerion is a clinical pharmacology and bioanalytical services CRO specializing in early-phase clinical research and bioanalysis (PK/PD/immunogenicity), directly comparable to Agilex's core offering for small and large molecules.
  • Eurofins Bioanalytical Services: Eurofins Bioanalytical Services provides regulated LC-MS/MS and ligand-binding bioanalysis for preclinical and clinical studies, overlapping directly with Agilex's PK, biomarker, and immunogenicity service lines.
  • Pharmaron: Pharmaron offers integrated drug discovery, development, and bioanalytical services including LC-MS/MS bioanalysis, in vivo PK, and immunology assays, serving as a direct competitor in bioanalytical CRO with both Western and APAC presence.

Broad incumbents

  • Charles River Laboratories: Charles River is a global preclinical and bioanalytical CRO providing safety assessment, bioanalysis, and research models. Its discovery/safety division overlaps with Agilex's GLP toxicology and bioanalytical services, though it operates at much greater scale.
  • WuXi AppTec: WuXi AppTec is a leading APAC-headquartered CRO/CDMO with bioanalytical, toxicology, and clinical research services, competing head-to-head with Agilex for global biotech clients seeking APAC bioanalytical capacity.
  • IQVIA: IQVIA is the world's largest CRO with end-to-end clinical, bioanalytical, and real-world evidence services. While not specialized like Agilex, it competes for full-service sponsor programs that include bioanalytical work.
  • ICON plc: ICON is a top-tier global CRO providing clinical development and bioanalytical services across all phases, comparable as a broad incumbent that bundles bioanalysis into integrated trial offerings.
  • Fortrea (formerly LabCorp Drug Development): Fortrea is a global clinical CRO spun out of LabCorp with bioanalytical and central lab capabilities, directly overlapping with Agilex's clinical bioanalysis and central lab services for biotech and pharma sponsors.
  • Intertek Pharmaceutical Services: Intertek provides pharmaceutical and bioanalytical testing services including LC-MS/MS and ligand-binding assays for regulated studies, comparable to Agilex's quality-control bioanalytical workflows.
  • SGS Health Sciences: SGS Health Sciences provides clinical research, bioanalytical, and central laboratory services to pharma and biotech, overlapping with Agilex's bioanalytical and central lab offerings from a global, multi-geography footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Agilex Biolabs social profiles

Digital presence

Agilex Biolabs compliance and trust

Trust signal

Compliance6 records

Agilex Biolabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agilex Biolabs leadership team

Management profile

Number of profiles

Profiles6 records

Agilex Biolabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agilex Biolabs M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agilex Biolabs

What does Agilex Biolabs do?

Agilex Biolabs is a contract research organization (CRO) providing regulated bioanalytical laboratory services for preclinical and clinical drug development. Its core offerings include Pharmacokinetics (PK) bioanalysis via LC-MS/MS and immunoassays, Pharmacodynamics (PD) testing including immunogenicity and flow cytometry, biomarker analysis, central lab services, GLP toxicology, PBMC processing, ELISpot, and immunogenicity testing — primarily serving biotech and pharma companies conducting clinical trials in Australia and globally.

Is Agilex Biolabs a public or private company?

Agilex Biolabs is a private company. It is classified as corporate owned and is currently operating.

When was Agilex Biolabs founded?

Agilex Biolabs was founded in 1996. It employs 101 to 250 people.

Where is Agilex Biolabs based?

Agilex Biolabs is headquartered in Thebarton, Australia, in the Oceania region.

How does Agilex Biolabs make money?

One revenue line is on record: contract Research Services (CRO).

Who are Agilex Biolabs's main competitors?

Direct peers on record are Celerion, Eurofins Bioanalytical Services and Pharmaron. Broad incumbents are Charles River Laboratories, WuXi AppTec, IQVIA, ICON plc, Fortrea (formerly LabCorp Drug Development), Intertek Pharmaceutical Services and SGS Health Sciences.

Does Agilex Biolabs have an API?

No public API is recorded for Agilex Biolabs.

What industry is Agilex Biolabs in?

Agilex Biolabs's product category is Bioanalytical Laboratory Services. Its primary akta.pro industry code is HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 621511 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmaTimesNovotech to acquire Agilex BiolabsNovotech agreed to acquire Agilex Biolabs, an Adelaide-based bioanalytical lab, from a Healius subsidiary. The deal adds Australian bioanalytical expertise to Novotech's Asia network and is subject to regulatory clearances. Novotech partners with over 5,000 trial sites.Pulse 2.0Novotech To Acquire Agilex Biolabs From Healius To Expand Australian Bioanalytical ServicesNovotech agreed to acquire Agilex Biolabs from Healius to expand its Australian bioanalytical laboratory services. The deal will add Agilex's Adelaide operations to Novotech's Asia-Pacific network, with financial terms undisclosed. Completion is subject to regulatory clearances, with no closing date set.Medical BuyerNovotech to acquire Agilex BiolabsNovotech agreed to acquire Agilex Biolabs, a bioanalytical laboratory in Adelaide, from Healius Limited. The deal adds Australian bioanalytical expertise to Novotech's Asia network, subject to regulatory clearances.FinancialContent Business PageNovotech to acquire Agilex BiolabsNovotech agreed to acquire Agilex Biolabs, a specialist bioanalytical laboratory in Adelaide, Australia, from a wholly owned subsidiary of Healius. The deal adds bioanalytical expertise to Novotech's existing laboratory network across Asia. Completion is subject to customary conditions, including regulatory clearances.The future of tradingHealius To Sell Agilex Biolabs To NovotechHealius Limited agreed to sell Agilex Biolabs to Novotech for an enterprise value of A$160 million, with completion anticipated in the second half of fiscal year 2027. The deal is expected to generate cash proceeds of about A$155 million.The future of tradingAustralia's Healius rises on sale of unit Agilex Biolabs to Novotech HealthHealius shares rose 18.1% to A$0.425 after agreeing to sell its unit Agilex Biolabs to Novotech Health's subsidiary for A$160 million. The deal expects cash proceeds of A$155 million after costs, and the company said the disposal would unlock shareholder value and support focus on its core Pathology business.Novotech-CroNovotech to acquire Agilex BiolabsNovotech agreed to acquire Agilex Biolabs, a specialist bioanalytical laboratory in Adelaide, Australia, from a Healius subsidiary. The deal adds bioanalytical expertise to Novotech's Asia laboratory network, enabling better R&D support for biotech and pharma sponsors in Australia. Completion is subject to customary conditions, including regulatory clearances.FinancialContent Business PageFlow Cytometry Services Market Report 2025, with Profiles of FlowMetric, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex BiolabsResearchAndMarkets.com added a market research report on the global flow cytometry services market to its offerings, valuing the market at USD 2.76 billion in 2025 and projecting a compound annual growth rate of 9.73% through 2035. The report identifies approximately 30 companies offering flow cytometry services, with the majority based in North America and over 70% providing analysis-based flow cytometric services. Key players profiled include FlowMetric Life Sciences, Q2 Solutions, Bio-Legend, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex Biolabs, with the report noting that market consolidation activity has increased in recent years through mergers and acquisitions.SGSSGS Joins Forces with Agilex BiolabsSGS announced a partnership with Agilex Biolabs, Australia’s largest regulated bioanalytical laboratory, to strengthen its global footprint in bioanalysis services. The collaboration enables clients to extend their bioanalytical services from Phase 1 to Phase 3 clinical trials, leveraging combined expertise and operationally aligned equipment across both organizations. SGS operates a global network of bioanalytical laboratories, including a newly opened Shanghai facility, and has over 30 years of experience in GLP/GCP compliant services.PR NewswireLe premier laboratoire bioanalytique satellite offre l'option la plus rapide pour le traitement des PBMC dans les essais cliniques australiensAgilex Biolabs installed its first satellite treatment unit on the fifth floor of CMAX Clinical Research's Adelaide facility, enabling peripheral blood mononuclear cell processing in the same building as trial participants. Blood samples move from patient to treatment in about 15 minutes, with results delivered days after collection.